Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hypertension, Pulmonary: full-pipeline trial registry
2 of 11 indexed Hypertension, Pulmonary trials are currently recruiting.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 2 currently recruiting · #1,577 of 28,707 conditions by registered trial count
Hypertension, Pulmonary: 11 US clinical trials tracked, 2 recruiting.
Hypertension, Pulmonary is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Richard Moon, running 1 of these trials.
Enrollment posture brief
Registry condition hypertension-pulmonary
OPEN 2 | RECR 18% | LATE 3 | EARLY 4 | RANK #1577 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome (18% recruiting · 22 trials)
Hypertension, Pulmonary lists 2 open slots (18% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hypertension, Pulmonary on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hypertension, Pulmonary is recruiting below its size-band peers.
2 of 11 indexed trials (18.2%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Hypertension, Pulmonary trials is spread across many organizations.
Richard Moon accounts for 1 of 11 trials (9.1%). 11 distinct sponsors appear on at least one study for this condition label.
-
Typical Hypertension, Pulmonary enrolment sits around 130 participants.
Median target enrolment is 130 among the 11 trials that report a genuine target (sentinel values excluded). 5 of those (45.5%) plan for fewer than 100 participants.
-
Hypertension, Pulmonary research is mostly interventional.
8 interventional and 3 observational studies make up this index (72.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
Eko Devices
NCT07087613
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
Merck Sharp & Dohme
NCT06814145
A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ U
NCT04945460
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension
Actelion
NCT04175600
Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD
Third Pole Therapeutics
NCT05867914
Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)
Bayer
NCT02576002
Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs
Eli Lilly and Company
NCT00549302
Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
Stanford University
NCT01516398
Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude
Richard Moon
NCT02024386
Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension
Carelon Research
NCT00872170
Dietary Nitrate for Heart Failure
Washington University School of Medicine
NCT01682356
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Hypertension, Pulmonary records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hypertension, Pulmonary trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hypertension, Pulmonary page
11 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Hypertension, Pulmonary trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Richard Moon sponsors the most Hypertension, Pulmonary trials on record, review their full trial history before evaluating a specific study. See Richard Moon's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hypertension, Pulmonary condition card totals 11 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.